AN-SLIM
Natural health product licensed in Canada
- Licence holder
- 2133979 Ontario Corp
- NPN or DIN-HM
- 80040895
- Status
- Inactive licence
- Licence date
- 14 March 2013
- Revision date
- 1 February 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Inuline Source : Cichorium intybus - racine | 50 mg | Not calculated |
| Inuline Source : Inuline | 50 mg | Not calculated |
| Chitosane Source : Chitosane Potency : 92 % Deacetylation | 250 mg | Not calculated |
| Malus domestica Source : Fruit | 20 mg | Not calculated |
| Brassica oleracea var. italica Source : En entier | 10 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Dioxyde de silicium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 days |
Uses authorised in Canada
To be used with a program of reduced intake of dietary calories and increased physical activity (if possible) to help in weight management. Source of anti oxidant for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant or breastfeeding. Do not use if you have primary systemic L-caritine deficiency or secondary L-carnitine deficiency (inborn errors in metabolism) for which levocarnitine supplementation is prescribed and/or monitored by a healthcare practitioner.
- Effets indésirables connus
Mild gastrointestinal symptoms (transient nausea, vomiting, abdominal cramps, and diarrhea) have been reported when taking L-carnitine. Low incidences of seizures have been reported with oral doses of L-carnitine in individuals with or without pre-existing seizure disorders.
Source
Official Health Canada record, licence 80040895
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging